Prot #B-VEC-03: A Phase III Efficacy and Safety Study of Beremagene Geperpavec (B-VEC, previously KB103) for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/22/2012/22/23

Funding

  • Krystal Biotech, Inc. ((OE) Prot #B-VEC-03)